Every year, the Gustave Roussy Foundation and CRIS Cancer Foundation run a programme to Award 1 Clinical Trial Proposal as part of the Real-Life Trials in Oncology Programme. 

The purpose is to fund trials led by a pair of principal investigators (one in France and one in Spain).  The number of proposals to be funded will be decided after selection, depending on ranking and individual budget submitted. The maximum amount to be funded per call is 1.5 M, 500.000€ annually for 3 years.

The programme invites applications from all specialist physicians who have a transformative clinical trial proposal and look for co-investigators in France or Spain to develop the trial.

The trial should run for a maximum of 3 years. In case of justifiable delay of the project, the principal investigators may ask for an extended period and the GRF-CCF Committee will evaluate to confirm or deny the extension.

The call for applications opens on 1st February 2022 and closes on 30th April 2022 at midnight (Central European Time – CET).

Beneficiaries must accept their place on the programme between 1st July and 31st December 2022. The start date must be communicated to the Gustave Roussy Foundation and CRIS Cancer Foundation prior to that date. 

All the information here